{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:44:44Z","timestamp":1793137484598,"version":"4.5.0"},"reference-count":219,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2012,6,21]],"date-time":"2012-06-21T00:00:00Z","timestamp":1340236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Toxicol Pathol"],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:p>Preclinical toxicity studies have demonstrated that exposure of laboratory animals to liver enzyme inducers during preclinical safety assessment results in a signature of toxicological changes characterized by an increase in liver weight, hepatocellular hypertrophy, cell proliferation, and, frequently in long-term (life-time) studies, hepatocarcinogenesis. Recent advances over the last decade have revealed that for many xenobiotics, these changes may be induced through a common mechanism of action involving activation of the nuclear hormone receptors CAR, PXR, or PPAR\u03b1. The generation of genetically engineered mice that express altered versions of these nuclear hormone receptors, together with other avenues of investigation, have now demonstrated that sensitivity to many of these effects is rodent-specific. These data are consistent with the available epidemiological and empirical human evidence and lend support to the scientific opinion that these changes have little relevance to man. The ESTP therefore convened an international panel of experts to debate the evidence in order to more clearly define for toxicologic pathologists what is considered adverse in the context of hepatocellular hypertrophy. The results of this workshop concluded that hepatomegaly as a consequence of hepatocellular hypertrophy without histologic or clinical pathology alterations indicative of liver toxicity was considered an adaptive and a non-adverse reaction. This conclusion should normally be reached by an integrative weight of evidence approach.<\/jats:p>","DOI":"10.1177\/0192623312448935","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T12:04:06Z","timestamp":1340366646000},"page":"971-994","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":400,"title":["Liver Hypertrophy"],"prefix":"10.1177","volume":"40","author":[{"given":"A. P.","family":"Hall","sequence":"first","affiliation":[{"name":"AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. R.","family":"Elcombe","sequence":"additional","affiliation":[{"name":"CXR Biosciences, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. R.","family":"Foster","sequence":"additional","affiliation":[{"name":"AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Harada","sequence":"additional","affiliation":[{"name":"Institute of Environmental Toxicology, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Merck KGaA, Non-Clinical Development, Toxicology, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Knippel","sequence":"additional","affiliation":[{"name":"Merck KGaA, Non-Clinical Development, Toxicology, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"K\u00fcttler","sequence":"additional","affiliation":[{"name":"BASF SE, Dep. GV\/TD, Ludwigshafen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. E.","family":"Malarkey","sequence":"additional","affiliation":[{"name":"National Toxicology Program Pathology Group, Cellular and Molecular Pathology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. R.","family":"Maronpot","sequence":"additional","affiliation":[{"name":"Maronpot Consulting LLC, Raleigh, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Biological Safety Research Center, National Institute of Health Sciences, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Nolte","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharma GmbH & Co, Biberach\/Riss, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Schulte","sequence":"additional","affiliation":[{"name":"Bundesinstitut f\u00fcr Risikobewertung, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Strauss","sequence":"additional","affiliation":[{"name":"BASF SE, Dep. GV\/TD, Ludwigshafen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"York","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline R&D, Safety Assessment, Hertfordshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2012,6,21]]},"reference":[{"key":"bibr1-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1042\/bj0250777"},{"key":"bibr2-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(80)80123-5"},{"key":"bibr3-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1080\/01926230490440934"},{"key":"bibr4-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1006\/rtph.1998.1201"},{"key":"bibr5-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-6915(98)00066-0"},{"key":"bibr6-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-6915(01)00030-8"},{"key":"bibr7-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2005.08.027"},{"key":"bibr8-0192623312448935","unstructured":"Andrew D. (2005). PSD Guidance Document. Interpretation of liver enlargement in regulatory toxicity studies. http:\/\/www.pesticides.gov.uk\/resources\/crd\/migrated-resources\/documents\/a\/acp_paper_on_the_interpretation_of_liver_enlargement.pdf. Accessed July 29, 2011."},{"key":"bibr9-0192623312448935","unstructured":"Animal Welfare Information Center (2005). Food deprivation or water deprivation. Accessed\u00a0 July 7, 2011. http\/\/www.nal.usda.gov\/awic\/pubs\/iacuc\/food.htm."},{"key":"bibr10-0192623312448935","unstructured":"Aphis (1997). Policy #11,\n                      Animal Care Resource Guide\n                      . Accessed July 7, 2011. http:\/\/www.aphis.usda.gov\/animal_welfare\/downloads\/policy\/policy11.pdf."},{"key":"bibr11-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4274(81)90103-X"},{"key":"bibr12-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04674.x"},{"key":"bibr13-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2009.11.021"},{"key":"bibr14-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M300749200"},{"key":"bibr15-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00203.2003"},{"key":"bibr16-0192623312448935","first-page":"4875","volume":"55","author":"Beebe L. E.","year":"1995","journal-title":"Canc Res"},{"key":"bibr17-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1042\/bj2750247"},{"key":"bibr18-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0278-6915(93)90225-N"},{"key":"bibr19-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.21.12208"},{"key":"bibr20-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2005.02.004"},{"key":"bibr21-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1007\/BF00496780"},{"key":"bibr22-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0306-3623(89)90187-0"},{"key":"bibr23-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-483X(98)00006-7"},{"key":"bibr24-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.06.049"},{"key":"bibr25-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-165X.2005.tb00041.x"},{"key":"bibr26-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-165X.1983.tb00609.x"},{"key":"bibr27-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2003.12.018"},{"key":"bibr28-0192623312448935","volume-title":"Mouse Hepatic Neoplasia","author":"Butler W. H.","year":"1975"},{"key":"bibr29-0192623312448935","doi-asserted-by":"publisher","DOI":"10.3109\/10408444.2010.541225"},{"key":"bibr30-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.971051196"},{"key":"bibr31-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfi273"},{"key":"bibr32-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(96)04310-8"},{"key":"bibr33-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1002\/jemt.10327"},{"key":"bibr34-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1080\/01926230490451680"},{"key":"bibr35-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1006\/rtph.1997.1163"},{"key":"bibr36-0192623312448935","first-page":"3246","volume":"49","author":"Cattley R. C.","year":"1989","journal-title":"Cancer Res"},{"key":"bibr37-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.1984.sp002840"},{"key":"bibr38-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-5107(99)00237-7"},{"key":"bibr39-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9975(78)90014-2"},{"key":"bibr40-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/j.etp.2006.08.002"},{"key":"bibr41-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0015-6264(81)90509-5"},{"key":"bibr42-0192623312448935","volume":"103","author":"Conning D. M.","year":"1971","journal-title":"J Pathol"},{"key":"bibr43-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1080\/15287390500196487"},{"key":"bibr44-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/10.3.513"},{"key":"bibr45-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(77)90049-X"},{"key":"bibr46-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(77)90050-6"},{"key":"bibr47-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1097\/00012995-198912000-00001"},{"key":"bibr48-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/13.10.1893"},{"key":"bibr49-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0272-0590(85)90204-0"},{"key":"bibr50-0192623312448935","unstructured":"ECETOC Technical Report no 85: Recognition of, and Differentiation between Adverse and Non-adverse Effects in Toxicology Studies (2002)."},{"key":"bibr51-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1124\/mol.65.3.720"},{"key":"bibr52-0192623312448935","first-page":"19","volume":"3","author":"Edwards J. E.","year":"1942","journal-title":"J Natl Can Inst"},{"key":"bibr53-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(85)90135-8"},{"key":"bibr54-0192623312448935","volume":"114","author":"Elcombe C. R.","year":"2010","journal-title":"The Toxicologist CD\u2014An Official Journal of the Society of Toxicology"},{"key":"bibr56-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2010.09.022"},{"key":"bibr55-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2005.02.004"},{"key":"bibr57-0192623312448935","unstructured":"EMEA (2010). Reflection paper on non-clinical evaluation of drug-induced liver injury (DILI). EMEA\/CHMP\/SWP\/150115\/2006."},{"key":"bibr58-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfq144"},{"key":"bibr59-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1177\/0192623310374332"},{"key":"bibr60-0192623312448935","first-page":"251","volume":"5","author":"Eschenbrenner A. B.","year":"1945","journal-title":"J Natl Can Inst"},{"key":"bibr61-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4274(95)03324-E"},{"key":"bibr62-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.005389"},{"key":"bibr63-0192623312448935","first-page":"261","volume":"76","author":"Farber E.","year":"1980","journal-title":"Ciba Found Symp"},{"key":"bibr64-0192623312448935","unstructured":"FDA (2009). Guidance for industry: Drug-induced liver injury: Premarketing clinical evaluation. http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm174090.pdf. Accessed July 29, 2011."},{"key":"bibr65-0192623312448935","doi-asserted-by":"publisher","DOI":"10.3109\/10408444.2011.552063"},{"key":"bibr66-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1996.0210"},{"key":"bibr67-0192623312448935","doi-asserted-by":"publisher","DOI":"10.2174\/138620710790596727"},{"key":"bibr68-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64794-3"},{"key":"bibr69-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/19.7.1251"},{"key":"bibr70-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1354\/vp.42-2-147"},{"key":"bibr71-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M010173200"},{"key":"bibr72-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1002\/9780470516751.ch18"},{"key":"bibr73-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-483X(02)00281-0"},{"key":"bibr74-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1080\/01926230252929945"},{"key":"bibr75-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-6264(65)80129-8"},{"key":"bibr76-0192623312448935","first-page":"127","volume":"36","author":"G\u00f3gl A.","year":"1979","journal-title":"Acta Med Acad Sci Hung"},{"key":"bibr77-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1042\/bj1960337"},{"key":"bibr78-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.20173"},{"key":"bibr79-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0027-5107(91)90062-S"},{"key":"bibr80-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0015-6264(74)90006-6"},{"key":"bibr81-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/B978-044452771-4\/50010-9"},{"key":"bibr82-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1124\/mol.65.5.1159"},{"key":"bibr83-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(98)00058-8"},{"key":"bibr84-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-198612000-00004"},{"key":"bibr85-0192623312448935","unstructured":"HED Toxicology Science Advisory Council (2002). Hepatocellular hypertrophy. HED Guidance Document # g0201."},{"key":"bibr86-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1080\/01926230601178207"},{"key":"bibr88-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1272\/jnms1923.58.547"},{"key":"bibr89-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2009.01.007"},{"key":"bibr90-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1177\/019262339402200607"},{"key":"bibr91-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgh182"},{"key":"bibr92-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1042\/bj3470321"},{"key":"bibr93-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1006\/taap.2002.9378"},{"key":"bibr94-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1210\/me.2004-0520"},{"key":"bibr95-0192623312448935","unstructured":"ICH Guidance for Industry S1C(R2). Dose selection for carcinogenicity studies of pharmaceuticals, September 2008, Rev. 1."},{"key":"bibr96-0192623312448935","unstructured":"ICH Guidance for Industry M3(R2). Nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals, January 2010."},{"key":"bibr97-0192623312448935","volume-title":"Peroxisome proliferation and its Role in Carcinogenesis","author":"International Agency for Research on Cancer (IARC)","year":"1995"},{"key":"bibr98-0192623312448935","first-page":"1","author":"International Agency for Research on Cancer (IARC)","year":"1997","journal-title":"Eval Carcinog Risks Hum"},{"key":"bibr99-0192623312448935","volume":"79","author":"International Agency for Research on Cancer (IARC)","year":"2001","journal-title":"IARC monographs on the evaluation of carcinogenic risks to humans. Some thyrotropic agents"},{"key":"bibr100-0192623312448935","volume-title":"Modification of Tumour Development in Rodents","author":"Ito N.","year":"1991"},{"key":"bibr101-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1976.tb06746.x"},{"key":"bibr102-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1007\/BF01926353"},{"key":"bibr103-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2011.06.012"},{"key":"bibr104-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1080\/08958370802629610"},{"key":"bibr105-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.66.347"},{"key":"bibr106-0192623312448935","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2460\/ajvr.1981.42.04.575","volume":"42","author":"Keller P.","year":"1981","journal-title":"Am J Vet Res"},{"key":"bibr107-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.98106s1289"},{"key":"bibr108-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1210\/er.2001-0038"},{"key":"bibr109-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1097\/00129804-200503000-00004"},{"key":"bibr110-0192623312448935","first-page":"223","volume":"21","author":"Koch S.","year":"1997","journal-title":"Gastroenterol Clin Biol"},{"key":"bibr111-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1080\/01926230390202353"},{"key":"bibr112-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1007\/BF02544580"},{"key":"bibr113-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.1860080411"},{"key":"bibr114-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4274(95)03513-3"},{"key":"bibr115-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1080\/00498250903098184"},{"key":"bibr116-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(76)90038-X"},{"key":"bibr117-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0278-6915(93)90005-J"},{"key":"bibr118-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(89)90120-8"},{"key":"bibr119-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(76)90116-2"},{"key":"bibr120-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1042\/bj2760273"},{"key":"bibr121-0192623312448935","first-page":"355","author":"Lassen E. D.","year":"2004","journal-title":"Veterinary Hematology and Clinical Chemistry"},{"key":"bibr122-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.15.6.3012"},{"key":"bibr123-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(75)90102-X"},{"key":"bibr124-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3703"},{"key":"bibr125-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/93.4.546"},{"key":"bibr126-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/11.5.547"},{"key":"bibr127-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1080\/01926230252824725"},{"key":"bibr128-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-2797(02)00051-0"},{"key":"bibr129-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/501739"},{"key":"bibr130-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1080\/714044702"},{"key":"bibr131-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1007\/BF00499047"},{"key":"bibr132-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(74)90253-1"},{"key":"bibr133-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.90372.2008"},{"key":"bibr134-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4800(83)90054-0"},{"key":"bibr135-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2005.09.020"},{"key":"bibr136-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.4.7.895"},{"key":"bibr137-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M300138200"},{"key":"bibr138-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/16.11.2617"},{"key":"bibr139-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1177\/0192623389017004112"},{"key":"bibr140-0192623312448935","unstructured":"Maronpot R. R., Malarkey D. (2011). Case 5\u2014Environmental chemicals: Fire retardant and kava kava. 3rd International ESTP expert workshop."},{"key":"bibr141-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1177\/0192623310373778"},{"key":"bibr142-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0009-2797(79)90081-4"},{"key":"bibr143-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1007\/BF00798356"},{"key":"bibr144-0192623312448935","volume-title":"Growth Factors and Tumour Promotion. Implications for Risk Assessment","author":"Mcclain R. M.","year":"1995"},{"key":"bibr145-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2011.04.009"},{"key":"bibr146-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(85)90409-0"},{"key":"bibr147-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-0875"},{"key":"bibr148-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1210\/mend.16.5.0828"},{"key":"bibr149-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M001215200"},{"key":"bibr150-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgi329"},{"key":"bibr151-0192623312448935","unstructured":"National Toxicology Programme (2006). Specifications for the conduct of studies to evaluate the toxic and carcinogenic potential of chemical, biological and physical agents in laboratory animals for the national toxicology program (NTP)."},{"key":"bibr152-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00712-10"},{"key":"bibr153-0192623312448935","first-page":"26","volume":"251","author":"Niemegeers C. J.","year":"1981","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"bibr154-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1258\/002367702320162414"},{"key":"bibr155-0192623312448935","unstructured":"OECD Guidance Notes for analysis and evaluation of chronic toxicity and carcinogenicity studies, September 4, 2002."},{"key":"bibr156-0192623312448935","unstructured":"OECD Draft Guidance Document no. 116 on the design and conduct of chronic toxicity and carcinogenicity studies, supporting tg 452, 452 and 453. http:\/\/www.oecd.org\/dataoecd\/57\/32\/44076587.pdf."},{"key":"bibr157-0192623312448935","first-page":"62","volume":"116","author":"Ohta M.","year":"2001","journal-title":"Rinsho Byori"},{"key":"bibr158-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/81.10.803"},{"key":"bibr159-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1124\/mol.53.1.14"},{"key":"bibr160-0192623312448935","first-page":"1143","volume":"51","author":"Parzefall W.","year":"1991","journal-title":"Cancer Res"},{"key":"bibr161-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/18.11.2029"},{"key":"bibr162-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2003.11.016"},{"key":"bibr163-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1007\/BF00606684"},{"key":"bibr164-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1007\/BF00542550"},{"key":"bibr166-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1080\/00498250903098218"},{"key":"bibr165-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/19.9.1521"},{"key":"bibr167-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1161\/hq1101.098228"},{"key":"bibr168-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1159\/000138057"},{"key":"bibr169-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(86)90198-8"},{"key":"bibr170-0192623312448935","unstructured":"PSD Guidance Document: Toxicological significance of reduced levels of serum ALT and\/or AST in animal studies, 2007."},{"key":"bibr171-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/56.1.181"},{"key":"bibr172-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1998.4223"},{"key":"bibr173-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2011.05.1034"},{"key":"bibr174-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(79)90438-6"},{"key":"bibr176-0192623312448935","first-page":"268","volume":"122","author":"Regidor P. A.","year":"2000","journal-title":"Zentralbl gynakol"},{"key":"bibr177-0192623312448935","unstructured":"Regulation EC no. 1772\/2008 of the european parliament and of the council of\u00a0 december 16, 2008, on classification, labelling and packaging of substances and mixtures, annex 1, chapter 3.9"},{"key":"bibr175-0192623312448935","first-page":"275","volume":"85","author":"Reuber M. D.","year":"1968","journal-title":"Arch Pathol"},{"key":"bibr178-0192623312448935","first-page":"299","volume":"65","author":"Rhodes C.","year":"1986","journal-title":"Env Health Persp"},{"key":"bibr179-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1006\/faat.1993.1055"},{"key":"bibr180-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/57.2.326"},{"key":"bibr181-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.128605"},{"key":"bibr182-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(71)90093-6"},{"key":"bibr183-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfq118"},{"key":"bibr184-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1177\/019262338801600103"},{"key":"bibr185-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1080\/00028895909343730"},{"key":"bibr186-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1078\/0940-2993-00311"},{"key":"bibr187-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/65.1.135"},{"key":"bibr188-0192623312448935","first-page":"795","volume":"221","author":"Satoh T.","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"bibr189-0192623312448935","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i46.7551"},{"key":"bibr190-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2004.03.004"},{"key":"bibr191-0192623312448935","doi-asserted-by":"publisher","DOI":"10.3109\/10408447409079856"},{"key":"bibr192-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0009-2797(80)90018-6"},{"key":"bibr193-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0009-2797(80)90017-4"},{"key":"bibr194-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-67265-1_16"},{"key":"bibr195-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2005.05.008"},{"key":"bibr196-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1080\/01926230701595300"},{"key":"bibr197-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1080\/01926230590522086"},{"key":"bibr198-0192623312448935","first-page":"1467","volume":"29","author":"Staudinger J.","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"bibr199-0192623312448935","volume-title":"Mouse Liver Carcinogenesis. Mechanisms and Species Comparisons","author":"Stevenson D. E.","year":"1990"},{"key":"bibr200-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/17.7.1473"},{"key":"bibr201-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1124\/mol.61.1.1"},{"key":"bibr202-0192623312448935","first-page":"703","author":"Vandenberghe J.","year":"1996","journal-title":"Toxicology, Principles and Applications"},{"key":"bibr203-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1007\/978-90-481-2675-0_8"},{"key":"bibr204-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1177\/019262339602400301"},{"key":"bibr205-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/1059-1311(92)90024-U"},{"key":"bibr206-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.5.620"},{"key":"bibr207-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1177\/1091581811401920"},{"key":"bibr208-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1177\/019262339802600208"},{"key":"bibr209-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1126\/science.1060762"},{"key":"bibr210-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1038\/35038112"},{"key":"bibr211-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1021\/jf60130a015"},{"key":"bibr212-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5849.316"},{"key":"bibr213-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(96)00067-8"},{"key":"bibr214-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1080\/01926230252824699"},{"key":"bibr215-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1996.tb18645.x"},{"key":"bibr216-0192623312448935","unstructured":"WHO\/IPCS (2004). IPCS Risk Assessment Terminology, IPCS\/OECD Key Generic Terms used in Chemical Hazard\/Risk Assessment. World Health organization, Geneva. http:\/\/www.who.int\/ipcs\/methods\/harmonization\/areas\/ipcsterminologyparts1and2.pdf."},{"key":"bibr217-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1007\/BF02977789"},{"key":"bibr218-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1080\/01926230701618516"},{"key":"bibr219-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1177\/0192623311406934"},{"key":"bibr220-0192623312448935","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.231140698"}],"container-title":["Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0192623312448935","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0192623312448935","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0192623312448935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:34:07Z","timestamp":1777653247000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0192623312448935"}},"subtitle":["A Review of Adaptive (Adverse and Non-adverse) Changes\u2014Conclusions from the 3rd International ESTP Expert Workshop"],"short-title":[],"issued":{"date-parts":[[2012,6,21]]},"references-count":219,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1177\/0192623312448935"],"URL":"https:\/\/doi.org\/10.1177\/0192623312448935","relation":{},"ISSN":["0192-6233","1533-1601"],"issn-type":[{"value":"0192-6233","type":"print"},{"value":"1533-1601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,21]]}}}